The perils of boarding: A call to achieve parity in the delivery of acute psychiatric services for children with COVID-19

Boarding across pediatric healthcare systems is on the rise during the pandemic. Children with positive COVID-19 test results awaiting psychiatric placements in the emergency department or medical unit settings are at increased risk for decompensation with unmet psychiatric needs during a time of crisis marked by vulnerability. There is scant literature unveiling best practices on delivery of care for these patients to achieve acute crisis stabilization. Recent studies have uncovered substantial increases in mental health disorders among children during the pandemic compared to previous incidence and prevalence rates prior to the pandemic. From the published literature, two healthcare systems have initiated long-term planning, development, and implementation of biodome psychiatric units for patients with COVID-19 in need of acute crisis stabilization services. We sampled 100 acute inpatient child and adolescent psychiatric programs to discern their post-COVID positive clearance policies for admission. Findings were mixed among days of quarantine required, symptomology, covid-designated spaces vs. self-isolated rooms for psychiatric treatment, number of COVID negative retests, and additional considerations. We also review a range of considerations and recommendations for clinical practice and the health system in achieving parity in mental health care for these patients which in turn could contribute towards mitigating the rising global mental health crisis. Furthermore, increasing access to acute psychiatric services for these patients will also contribute towards the larger goal of the World Health Organization, Sustainable Developmental Goals of the United Nations, and Healthy People 2030 in increasing accessibility, quality and equity of mental health care for individuals on both global and national frontiers.


Introduction
The outbreak of the COVID-19 disease caused an emergency situation worldwide by affecting various aspects of human life. Although preventive measures, such as social distancing, wearing face masks in public, being under lockdowns, and quarantines helped to control COVID-19 virus transmission, returning to normal life urgently needed long-term solutions such as universal vaccination. 1 COVID-19 vaccine reduced the mortality rate of disease and consequently had many benefits on the health and socio-economic aspects of life in the COVID-19 era. 2 Additionally, the vaccines against the coronavirus changed the course of the pandemic to a better status by reducing the severity of COVID-19 disease and the incidence of new cases, even among unvaccinated people, through herd immunity. 2 However, the COVID-19 vaccine, like all other new vaccines, faces the age-old public acceptance problem. 3 Therefore, not only discovering and making available the COVID-19 vaccine is one of the critical challenges for the policymakers, but it will also be essential to encourage people to get it. 4 Even though the effectiveness and safety of many vaccines, such as COVID-19, have been well established, many people consider vaccines unnecessary and doubt their effectiveness and safety. 2 Vaccine hesitancy is defined as a postponement in acceptance or denial despite the availability of a vaccine. 5 It has been declared one of the top 10 warnings to attaining health for all by the World Health Organization (WHO). 2 Vaccine hesitancy has existed since the advent of the vaccines for influenza, human papillomavirus, polio, measles, etc. 3 Recently, the world has witnessed people's hesitation to receive the COVID-19 vaccine. 6 COVID-19 vaccine hesitancy threatened doubtful people and the entire society by delaying the threshold of vaccine uptake necessary to achieve herd immunity. 2 The acceptance rate of the COVID-19 vaccine in different countries varied from the lowest of 23.6% in Kuwait to 97% in Ecuador. 6 In contrast, for successful control of COVID-19, the vaccine hesitancy should not be more than 25%-30%. 7 study designs. Systematic reviews were excluded but were employed to identify additional eligible studies.
The search strategy was conducted in accordance with the Peer Review of Electronic Search Strategies statement. 11 To ensure whether studies met the inclusion criteria, two authors conducted separate searches, screen the titles and abstracts, and then assessing the remaining 106 publications' full texts.

Screening the full-text and synthesis
For evaluation studies, information extracted included details about study characteristics, participants, setting, the prevalence of hesitation, and the findings related to the outcomes of interest.
Two research team members, SP and ZF, independently pilot-tested the data extraction form utilizing two of the 106 articles and compared and discussed the findings. The feedback was used to refine the form. The final draft of the form was used by SP to extract data from the remaining 104 articles, which were independently checked by ZF. Title and abstract screening, along with full-text screening and cross-validation, were conducted by two review authors (SP and ZF) independently based on the abovementioned inclusion criteria. Any disagreements over a particular study were resolved through mutual discussion with a third reviewer (HA). Subsequently, 18 of the 106 articles were removed, resulting in a final included sample of 88 studies. Studies were excluded if they did not evaluate hesitancy toward COVID-19 vaccine and just measured vaccine acceptance. In addition, those studies which have not pointed out the role of cognitive determinants in hesitancy to the COVID-19 vaccine were eliminated.
We added three additional articles to our enumeration by reviewing the references from the articles. Figure 1 depicts the selection process over four-rounds. Using the PRISMA flow diagram, the documentation and summarization of the identification, screening, eligibility, and selection processes was done. Finally, at total of 91 articles were independently reviewed by SP and ZF. After that relevant data were extracted, and if there were any discrepancies, they were resolved for 100% agreement.

Quality assessment
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement was used to conduct qualitative assessment independently with the help of two reviewers (SP and ZF). 12 This checklist incorporates 22 criteria. If a study meets a condition, it receives one point, or zero if it is not or only partially disclosed. In this rating a higher overall score means that there is less of methodological bias. We divided each study's risk of bias score by 22 (the highest possible score) and then multiplied it by 100 to assess the proportional percentage of fulfilled criteria. Any dissenting issues between the reviewers were resolved through discussion and consensus with the help of a third reviewer (HA). Studies' quality were then sorted into excellent (matching ≥ 85% criteria), good (matching

Risk of bias
On average the studies met 68.5% (range = 51-86%) of the rating criteria. On the whole, the studies showed a moderate risk of bias, and more than half of them (n = 63; 69%) were of good quality (range = 70 to 85).

Variations in vaccine hesitancy and refusal
Vaccination hesitation rate varied from 4% among patients with primary ciliary dyskinesia 16 to 74.3% (mean = 29.72) in people over 18 years of age living in Kuwait 20 and reported refusal rates were 8.6% to 75.5% (mean = 26.88). In addition to the hesitancy rate, some studies also measured uncertainty (mean = 23.25), undecided (mean = 29.4), and reluctance (mean = 24.15).

Cognitive Determinants of COVID-19 Vaccine Hesitancy
Among the evaluated peer-reviewed literature, based on a collective sample of 1 335 139 participants, several categories of cognitive determinants were extracted:

Perceived self-efficacy and perceived behavioral control
According to studies, individuals with higher general selfefficacy and specific self-efficacy of preventing COVID-19 displayed stronger intentions to get vaccinated. 67,97 In

Anti-vaccine beliefs
We found that conspiracy theories concerning the COVID-19 vaccine have a significant impact on decision to hesitate. For example, some related beliefs were as follows: (i) Vaccine protection against COVID-19 is temporary; (ii) COVID-19 vaccines modify DNA; iii) the vaccine can induce other disorders such as autism or autoimmune diseases; (iv) COVID-19's vaccine has chips implanted to control people; (v) the vaccine's efficacy and published studies are untrue 37 ; (vi) The virus is manufactured by humans ; (vii) the virus's spread is an deliberate attempt to reduce the global population's growth; and viii) COVID-19 is a biological weapon produced by China to crush the West. 50

Stress and anxiety
Perceived stress has been used as a factor associated with COVID-19 vaccine hesitancy by de Sousa et al in Portuguese-speaking countries. They found a significant direct relationship between vaccine hesitancy and perceived stress. 37 According to Xu et al, parents with psychological distress are more likely to hesitate to vaccinate for themselves, their spouses, and their children. 94 Feeling agitated, sad, or anxious were other factors that were shown to be associated with vaccine hesitancy in a survey conducted by Gomes et al. 47 Fears and concerns Some studies reported fears such as fear of needles and injection, 30 fear of infecting significant others, 41 and higher personal financial concerns/fear of the expensive vaccination costs, which make people hesitate to adopt the COVID-19 vaccination. Additionally, the Ghaffari-Rafi et al study showed that patients with an insight into a preexisting medical condition believed that COVID-19 vaccination might threaten their health because of existing disease. 45

Optimism
Optimism indicates the extent to which people hold positive expectancies for their future 100 used by Schernhammer et al. They explored the correlation of optimism with hesitancy toward COVID-19 and reported that persons with medium to high optimism were less prone to vaccine-hesitancy. 78

Personality traits
Some personality traits such as personal anomie, altruism, conscientiousness, agreeableness, and neuroticism have been used by several studies 9,18,96 as psychological indicators of vaccine hesitancy. These studies indicated that higher levels of neuroticism, perceptions of anomie, and lower levels of agreeableness, conscientiousness, and altruism might influence the increase in COVID-19 vaccine hesitancy.

Discussion
This systematic review aimed to investigate the cognitive determinants of COVID-19 vaccination hesitancy. We discuss several cognitive factors that may play a role in COVID-19 vaccine hesitancy. Confidence and complacency, two antecedents of the 5C psychological model, were among the most common cognitive factors studied to explain COVID-19 vaccine hesitancy. The confidence was relevant to trust in the government's decisions, the effectiveness of the vaccines, and the COVID-19 Vaccine delivery system. 101 Confidence in the COVID-19 vaccine and concerns about its safety have been reported in most studies. 5,14,20,29,31,38 According to studies, concerns about the probable side effects of the vaccine, its ingredients, its effectiveness, and safety, as well as the rapid process of vaccine production and the vaccines approval process, reduce the trust of people in the COVID-19 vaccine. Although most of the side effects of COVID-19 vaccines have been confirmed scientifically, some are undocumented or have fewer shreds of evidence. This can lead to insufficient knowledge, the formation of improper beliefs, incorrect information, and mistrust in vaccines. 102 When a vaccine is quickly produced and distributed, information sources such as the Internet and other social media disseminate claims about its harms and ineffectiveness. 103,104 Much of this information may exaggerate risks associated with the COVID-19 vaccines 105 and could cause the formation of anti-vaccine conspiracy beliefs. 106,107 Most of the information that is published by unreliable sources targets the safety of vaccines, worries people about short-term adverse reactions and possible long-term effects of the COVID-19 vaccine, and can ultimately lead to hesitation and refusal to vaccinate. 105 On the other hand, confidence in vaccines can result from people's trust in the public health care system and in delivering safe and effective vaccines. 101 In this regard, the WHO vaccine advisory group highlights the role of healthcare workers in building confidence in COVID-19 vaccines. Because healthcare providers can be effective in improving people's insights and awareness about the benefits of vaccination and addressing people's concerns about newly developed vaccines. 108 The role of distrust of the government and health care system is significant in causing vaccine hesitancy. 28,30,41,97 Usually, people are worried about the side effects of vaccines imported to the country or manufactured there, which may lead to a lack of trust and fear about vaccines. 7 The lower the people's trust in the government, the more risk perception of the threat. Therefore, governments should provide safe vaccines. 69 In fact, trust in the government and health authorities is essential for vaccine acceptance, especially in cases such as COVID-19, where anxiety about the nature of the disease is significant. 101 When the nature of a disease is not completely clear, the chance of spreading conspiracy beliefs may increase, and it was recognized that in the COVID-19 pandemic, the growth of conspiracy beliefs and the reduction of people's participation in vaccination have occurred. 9 Conspiracy theories explain the negative emotions and uncertainty that traditionally increase during times of social crisis (such as war, environmental disaster, and terrorism). In this situation, uncertainty, powerlessness, and fear and anxiety increase. 9 With the rapid prevalence of the COVID-19 pandemic, a wide range of conspiracy beliefs emerged and spread. For example, COVID-19 is a hoax, a biological weapon developed by the Chinese, and the COVID-19 vaccine microchips will be injected to control COVID- 19,9,109 which indicates that the vaccine manufacturing companies underestimate the side effects of the vaccines. 9 The development of such beliefs may cause mistrust and reduce the vaccination acceptance rate. Therefore, delivering information that focuses on the effectiveness and safety of the COVID-19 vaccine from reliable sources can be influential in reducing vaccination hesitancy.
The second antecedent of 5c psychological is complacency. More complacency is defined as a lower perceived threat of disease and the belief that vaccination is unnecessary as a preventive measure. In other words, people with high complacency have more feelings of invulnerability and less preventive behavior than those with low complacency. 101 According to the Health Belief Model (HBM), people are most likely to take a preventative behavior when they perceive the threat of disease. The HBM is one of the most widely used models to explain vaccination behavior. 6,110 Studies have shown that worrying about getting infected with COVID-19 and believing in the seriousness of its consequences can persuade people to get the COVID-19 vaccine. 6,111 Also, the newer fourth-generation models, such as the multi-theory model of health behavior change, have underscored the role of getting convinced of the advantages of behavior change over the disadvantages and building behavioral confidence. 87 One of the important factors in getting the vaccine is the perceived benefits of a vaccine. Such as the belief in its protective effect against COVID-19 and its subsequent side effects are among the influential factors in adherence to the COVID-19 vaccine. 111 In contradiction of that, perceived physical and psychological barriers that can make the vaccine an unpleasant experience 21,111 and concerns about safety and its probable side effects, fear of needles, and its costs can increase vaccination hesitancy. 112,113 Locus of control and belief in chance were other cognitive factors recognized in this study. Health locus of control refers to the degree to which a person believes that he/she, as opposed to external forces, has control over his/ her health. Locus of control is conceptualized as internal or external. 114 The internal dimension is positively associated with engaging in health behaviors, and chance as the external dimension is positively related to nonadherence to health behaviors. 115 People whose health locus of control is external may be doubtful about how to behave in a healthy manner, 116 such as vaccination, and it is reported that the external locus of health control is related to a lower level of childhood vaccination through parental attitudes.
Studies have used self-efficacy and perceived behavioral control as predictors of COVID-19 vaccine hesitancy. 6,67,97 As self-efficacy reflects one's belief in their ability to perform a particular behavior, 110 like the COVID-19 vaccination, perceived behavioral control similar to self-efficacy also refers to the person's belief that the considered behavior is under control. As a result, most psychosocial health behavior theories postulated that self-efficacy and perceived behavioral control had been introduced as major determinants of engaging in health behavior. 110 Also, the role of behavioral confidence has been underscored in the newer fourth-generation models, such as the multi-theory model (MTM) of health behavior change.

Limitations
Due to resource constraints needed to translate and retranslate studies published in other languages, the investigation was limited to manuscripts published in English only. Hence the results are not representative of research published in other languages. Further, the search in this review was limited to the title, keywords, and abstract of each publication. Perhaps more in-depth search could have resulted in identification of more studies. A single statistical analysis of the data was not practical or feasible because of the sizable variability in the cognitive determinants of COVID-19 across studies. Therefore, a narrative analysis was accomplished, thereby limiting the external validity of the conclusions.

Implications for practice and future research
Given that hesitancy and distrust of a new health product and service such as the COVID-19, vaccine will always exist, the development of strategies that can build trust in people to vaccinate and improve the government's ability to manage and successfully implement mass vaccination calls for attention. According to studies, several factors can contribute to building trust 117 : Responsiveness: Health authorities should show competence in responding to people's health needs, fears, and concerns by establishing a transparent and coherent relationship about the vaccine quality. Qualitative research can help identify people's needs, concerns, and fears about the COVID-19 vaccination.
Openness: The public must understand the importance of rapid vaccine production and distribution to achieve herd immunity during new epidemics. Also, more importantly, people should ensure that no quality or safety standards have been sacrificed for speed in the vaccine production process. Therefore, people should be informed about all phases of production, approval, evaluation, and distribution of vaccination through a proper communication strategy. Paying attention to myths, misconceptions, and false information about vaccination, monitoring the messages of widely used social media such as the Internet, spreading correct information through the creation and introduction of reliable information sources, and increasing health literacy and e-health literacy of people are other strategies for considering openness.
Reliability, integrity, and fairness: Holding campaigns to encourage people to take the vaccine with the presence of health authorities, pioneering them in receiving the vaccine, and providing information about all the benefits and harms of the vaccine, will increase confidence in the vaccination.

Conclusion
COVID-19 vaccine hesitancy as a significant challenge for public health has been reported in many countries. Our findings highlight the importance of understanding the cognitive factors contributing to COVID-19 vaccine hesitancy to develop effective health communication programs for persuading people toward COVID-19 vaccination and the most common reason for vaccine hesitancy was a lack of confidence and complacency. Multiple factors, including concerns about vaccine safety and side effects, perceived susceptibility and severity, the risk posed by COVID-19, and risk propensity, could influence delay or refusal to accept the vaccine. Information through trusted sources to reduce hesitancy about the COVID-19 vaccination.